This episode unpacks the significant variations in "Class III" and "Class IV" medical device classifications across key global markets like the US, EU, Canada, China, and Saudi Arabia. We explore why a device's risk class in one country doesn't automatically apply elsewhere and what this means for manufacturers seeking international market access. Key Questions: • Why isn't a Class III device in the USA treated the same as a Class III in the European Union or Canada? • Which major global markets utilize a Class IV for medical devices, and what specific risks does it cover? • How do fundamental risk definitions for medical devices differ from one regulatory authority to another? • What are the direct regulatory and compliance implications for manufacturers due to these classification differences? • Does the US FDA recognize a Class IV for medical devices, or is Class III its highest tier? • How does the EU's Medical Device Regulation (MDR) categorize its most critical, high-risk devices? • What distinguishes Canada's Class IV medical devices from its Class III devices in terms of risk and scrutiny? • How should medical device companies strategically approach global registration considering these diverse classification systems? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.